That means weekly shots are often needed in the beginning to keep energy and mood consistently up
Batterham, M.B., B.S., Ph.D., Salvatore Calanna, Ph.D., Melanie Davies, M.D., Luc F
In this Pharmaceutical Online live discussion led by Katie Anderson, Hyung Heon Kim (HH) Kim, CEO of MetaVia, joins Doug Bakan, Ph.D
For researchers tracking this space, the key trials to watch in 2026 include the remaining TRIUMPH program readouts for retatrutide, the GLORY-OSA trial for mazdutide in obstructive sleep apnea, and the first Phase 1 data from several quadruple-agonist programs entering clinical development
We monitor your GIP and GLP-1 receptor sensitivity to determine if a transition will break through the resistance and restart your transformation